Health & Medicine · Oncology
EACR Overcoming Therapy Resistance: Outsmarting intratumour heterogeneity and plasticity

About & call for papers
This new EACR conference topic will tackle one of oncology’s most persistent challenges: why do tumours adapt and resist therapy? Grounded in the core biology of intratumour heterogeneity (ITH) and cellular plasticity, the meeting emphasises therapy in its br… Read more
This new EACR conference topic will tackle one of oncology’s most persistent challenges: why do tumours adapt and resist therapy?
Grounded in the core biology of intratumour heterogeneity (ITH) and cellular plasticity, the meeting emphasises therapy in its broad sense – from targeted agents and immunotherapies to combination regimens. A central theme is the tumour immune microenvironment (TIME) perspective: how treatment location and timing, shaped by the tumour’s spatial and temporal evolution and its microenvironment, influence outcomes and create opportunities for intervention.
We’ll bring together international leaders of the field to illuminate how tumour complexity evolves, explore strategies to identify driver cell states and dissect and rewire the tumour microenvironment, and examine cutting-edge approaches to counter ITH and plasticity.
The target audience for this conference is researchers, clinicians, and allied health professionals focused on cancer biology, translational cancer research, medical oncology, and immunotherapy who want to translate insights on ITH, plasticity, and therapy timing into better patient care.
Speakers: Nicola Aceto (ETH Zurich, Switzerland) | Toni Celia-Terrassa (Hospital del Mar Research Institute, Spain) | Frederic de Sauvage (Genentec, USA) | Karuna Ganesh (MSKCC, USA) | Ernesto Guccione (Icahn School of Medicine at Mount Sinai, USA) | Marta Kovatcheva (IFOM, Italy) | Ilaria Malanchi (Francis Crick Institute, UK) | Chris Marine (VIB-KU Leuven Center for Human Genetics, Belgium) | Anna Obenauf (IMP, Austria) | Caroline Robert (Gustave Roussy Institute, France) | Raphael Rodriguez (Institut Curie, France) | Christoph Scheiermann (University of Geneva, Switzerland) | Tuomas Tammela (MSKCC, USA) | Manuel Valiente (CNIO, Spain) | Caline Vallot (Institut Curie, France) | Ashani Weeraratna (Johns Hopkins, USA)
Keywords: cancer research, oncology, cancer therapy resistance, intratumour heterogeneity, cell plasticity, immunotherapy, tumour immune microenvironment, driver cell states, TME rewiring, MICs, persister cells, tumour dormancy, treatment timing, treatment sequencing
Deadlines: Travel Grant application deadline: 15 February 2027 Abstract submission deadline: 15 February 2027 Registration deadline: 22 March 2027
Key dates
Add abstract submission closes to calendar
Add registration closes to calendar
Add the conference to calendar
Closing dates are Anywhere on Earth (AoE) unless the organizer stated otherwise.
Venue
Ecole Normale Superieure de Lyon (SITE MONOD) Amphitheatre Charles Merieux Pl. de l'Ecole, 69007 Lyon Cedex 07
Lyon, France
Open ENS de Lyon in maps ↗The address is as the organizer gave it, and it is not checked against a map.
Similar conferences
Health & Medicine · Oncology
Global Summit on Cancer Research and Novel Drug Development
Health & Medicine · Oncology
Global Summit on Cancer Research and Novel Drug Development

Health & Medicine · Oncology


